Selected research
Market Structure
Global Therapeutic BCG Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Therapeutic BCG Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Therapeutic BCG Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Therapeutic BCG Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Therapeutic BCG Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Therapeutic BCG Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Therapeutic BCG Vaccines include Serum Institute of India, Sanofi Pasteur, Merck, Japan BCG Lab, Intervax and GSBPL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Therapeutic BCG Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Therapeutic BCG Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Therapeutic BCG Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Therapeutic BCG Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.
Therapeutic BCG Vaccines Segment by Company
Serum Institute of India
Sanofi Pasteur
Merck
Japan BCG Lab
Intervax
GSBPL
Therapeutic BCG Vaccines Segment by Type
2ml Package
1ml Package
0.5ml Package
Others
Therapeutic BCG Vaccines Segment by Application
Hospitals
Clinics
Others
Therapeutic BCG Vaccines Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic BCG Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic BCG Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic BCG Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Therapeutic BCG Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic BCG Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Therapeutic BCG Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Therapeutic BCG Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 2ml Package
- 1ml Package
- 0.5ml Package
- Others
Applications
- Hospitals
- Clinics
- Others
Companies covered
- Serum Institute of India
- Sanofi Pasteur
- Merck
- Japan BCG Lab
- Intervax
- GSBPL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Therapeutic BCG Vaccines Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Therapeutic BCG Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Therapeutic BCG Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Therapeutic BCG Vaccines Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Therapeutic BCG Vaccines Market Dynamics
- 2.1 Therapeutic BCG Vaccines Industry Trends
- 2.2 Therapeutic BCG Vaccines Industry Drivers
- 2.3 Therapeutic BCG Vaccines Industry Opportunities and Challenges
- 2.4 Therapeutic BCG Vaccines Industry Restraints
3 Therapeutic BCG Vaccines Market by Manufacturers
- 3.1 Global Therapeutic BCG Vaccines Revenue by Manufacturers (2021-2026)
- 3.2 Global Therapeutic BCG Vaccines Sales by Manufacturers (2021-2026)
- 3.3 Global Therapeutic BCG Vaccines Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Therapeutic BCG Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Therapeutic BCG Vaccines Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Therapeutic BCG Vaccines Manufacturers, Product Type & Application
- 3.7 Global Therapeutic BCG Vaccines Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Therapeutic BCG Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Therapeutic BCG Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Therapeutic BCG Vaccines Tier 1, Tier 2, and Tier 3
4 Therapeutic BCG Vaccines Market by Type
- 4.1 Therapeutic BCG Vaccines Type Introduction
- 4.1.1 2ml Package
- 4.1.2 1ml Package
- 4.1.3 0.5ml Package
- 4.1.4 Others
- 4.2 Global Therapeutic BCG Vaccines Sales by Type
- 4.2.1 Global Therapeutic BCG Vaccines Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Therapeutic BCG Vaccines Sales by Type (2021-2032)
- 4.2.3 Global Therapeutic BCG Vaccines Sales Market Share by Type (2021-2032)
- 4.3 Global Therapeutic BCG Vaccines Revenue by Type
- 4.3.1 Global Therapeutic BCG Vaccines Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Therapeutic BCG Vaccines Revenue by Type (2021-2032)
- 4.3.3 Global Therapeutic BCG Vaccines Revenue Market Share by Type (2021-2032)
5 Therapeutic BCG Vaccines Market by Application
- 5.1 Therapeutic BCG Vaccines Application Introduction
- 5.1.1 Hospitals
- 5.1.2 Clinics
- 5.1.3 Others
- 5.2 Global Therapeutic BCG Vaccines Sales by Application
- 5.2.1 Global Therapeutic BCG Vaccines Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Therapeutic BCG Vaccines Sales by Application (2021-2032)
- 5.2.3 Global Therapeutic BCG Vaccines Sales Market Share by Application (2021-2032)
- 5.3 Global Therapeutic BCG Vaccines Revenue by Application
- 5.3.1 Global Therapeutic BCG Vaccines Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Therapeutic BCG Vaccines Revenue by Application (2021-2032)
- 5.3.3 Global Therapeutic BCG Vaccines Revenue Market Share by Application (2021-2032)
6 Global Therapeutic BCG Vaccines Sales by Region
- 6.1 Global Therapeutic BCG Vaccines Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Therapeutic BCG Vaccines Sales by Region (2021-2032)
- 6.2.1 Global Therapeutic BCG Vaccines Sales by Region (2021-2026)
- 6.2.2 Global Therapeutic BCG Vaccines Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Therapeutic BCG Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Therapeutic BCG Vaccines Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Therapeutic BCG Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Therapeutic BCG Vaccines Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Therapeutic BCG Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Therapeutic BCG Vaccines Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Therapeutic BCG Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Therapeutic BCG Vaccines Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Therapeutic BCG Vaccines Revenue by Region
- 7.1 Global Therapeutic BCG Vaccines Revenue by Region
- 7.1.1 Global Therapeutic BCG Vaccines Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Therapeutic BCG Vaccines Revenue by Region (2021-2026)
- 7.1.3 Global Therapeutic BCG Vaccines Revenue by Region (2027-2032)
- 7.1.4 Global Therapeutic BCG Vaccines Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Therapeutic BCG Vaccines Revenue (2021-2032)
- 7.2.2 North America Therapeutic BCG Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Therapeutic BCG Vaccines Revenue (2021-2032)
- 7.3.2 Europe Therapeutic BCG Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Therapeutic BCG Vaccines Revenue (2021-2032)
- 7.4.2 Asia-Pacific Therapeutic BCG Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Therapeutic BCG Vaccines Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Therapeutic BCG Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Serum Institute of India
- 8.1.1 Serum Institute of India Company Information
- 8.1.2 Serum Institute of India Business Overview
- 8.1.3 Serum Institute of India Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Serum Institute of India Therapeutic BCG Vaccines Product Portfolio
- 8.1.5 Serum Institute of India Recent Developments
- 8.2 Sanofi Pasteur
- 8.2.1 Sanofi Pasteur Company Information
- 8.2.2 Sanofi Pasteur Business Overview
- 8.2.3 Sanofi Pasteur Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanofi Pasteur Therapeutic BCG Vaccines Product Portfolio
- 8.2.5 Sanofi Pasteur Recent Developments
- 8.3 Merck
- 8.3.1 Merck Company Information
- 8.3.2 Merck Business Overview
- 8.3.3 Merck Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Merck Therapeutic BCG Vaccines Product Portfolio
- 8.3.5 Merck Recent Developments
- 8.4 Japan BCG Lab
- 8.4.1 Japan BCG Lab Company Information
- 8.4.2 Japan BCG Lab Business Overview
- 8.4.3 Japan BCG Lab Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Japan BCG Lab Therapeutic BCG Vaccines Product Portfolio
- 8.4.5 Japan BCG Lab Recent Developments
- 8.5 Intervax
- 8.5.1 Intervax Company Information
- 8.5.2 Intervax Business Overview
- 8.5.3 Intervax Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Intervax Therapeutic BCG Vaccines Product Portfolio
- 8.5.5 Intervax Recent Developments
- 8.6 GSBPL
- 8.6.1 GSBPL Company Information
- 8.6.2 GSBPL Business Overview
- 8.6.3 GSBPL Therapeutic BCG Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GSBPL Therapeutic BCG Vaccines Product Portfolio
- 8.6.5 GSBPL Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Therapeutic BCG Vaccines Value Chain Analysis
- 9.1.1 Therapeutic BCG Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Therapeutic BCG Vaccines Production Mode & Process
- 9.2 Therapeutic BCG Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Therapeutic BCG Vaccines Distributors
- 9.2.3 Therapeutic BCG Vaccines Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst